Last edition
News about " New Rule on Reporting RequirementUnder Right to T"
FDA Proposes New Rule on Reporting RequirementUnder Right to Try Act
Today, the U.S. Food and Drug Administration published the proposed rule, Annual Summary Reporting Requirements Under the Right to Try Act, that when finalized, will implement a statutory requirement for sponsors and manufacturers to provide annual summary to the FDA for any eligible investigational drug they provide to eligible patients under Try Act
New Rule On Reporting RequirementUnder Right To T | 27/07/2020 | By Darshana | 564
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy